FDA Approves Cosentyx for Hidradenitis Suppurativa Treatment

FDA Approves Cosentyx for Hidradenitis Suppurativa Treatment

The FDA just approved Cosentyx (secukinumab) for Hidradenitis Suppuritiva (HS). Hidrandenitis Suppurativa is a painful, long-term skin condition that causes skin abscesses and scarring.  This is one of the newest drugs approved for the condition.  Cosentyx is used in...

Pin It on Pinterest